 |
Prospector
Profile
07.1056
|
| |
| Health Chem Corporation |
NAICS |
325412 |
| 101 Sinking Springs Lane
Emigsville, PA 17318 |
Description |
Pharmaceutical Products Mfg. |
| (717) 764-1191 |
Employees |
55 |
|
Revenue |
(mil) |
5.9400 |
| |
Income |
(mil) |
-1.6560 |
| |
Assets |
(mil) |
5.7930 |
| |
Liability |
(mil) |
22.3790 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Health Chem Corp.'s consolidated balance sheet at March 31, 2007, showed $5.3 million in total assets, $22.4 million in total liabilities, and $3,000 in minority interest, resulting in a $17.1 million total stockholders' deficit. The Company's consolidated balance sheet at March 31, 2007, also showed strained liquidity with $3.6 million in total current assets available to pay $20.2 million in total current liabilities. The Company reported a net loss of $522,000 on net sales of $1.1 million for the first quarter ended March 31, 2007, compared with a net loss of $345,000 on net sales of $1.6 million for the same period ended March 31, 2006.
|
| |
|
Intellectual Property:
The Company seeks to obtain patent protection on its delivery systems and manufacturing processes whenever possible. The Company has obtained 11 United States and foreign patents and trademarks relating to its transdermal delivery systems and manufacturing processes. It also attempts to protect proprietary information under trade secret and confidentiality agreements. [SEC Filing 10-KSB 04-18-07]
|
| |
|
Description:
The Company develops, manufactures and markets transdermal drug delivery systems and undertake research and development activities for third parties on a contract basis.
|
| |
|
Officers:
Andy E. Yurowitz (Chair, Pres. & CEO); Ronald J. Burghauser (CFO, Treas. & Sec.); Andrew J. Levinson (Dir.); Manfred Mayerfeld (Dir.)
|
| |
|
Auditor:
Demetrius & Company LLC
|
| |
|
Securities:
Common Stock-Symbol HCLC.PK; Other OTC;
11,443,424 common shares outstanding as of March 30, 2007.
|
| |
| |
| |
| return to main page |
|
|
